News

Bill Gates, GV, and Foresite help Cerevance close $45 million in Series B financing

Cerevance will use the proceeds of the financing to continue identifying novel therapeutic targets for central nervous system diseases, such as Alzheimer’s disease.

Read More

Apr 15, 2020

By : Team ABLE

Indo-U.S. Science and Technology Forum invites proposals for ‘COVID-19 Indo-U.S. Virtual Networks

The Indo-U.S. Science and Technology Forum invites proposals for ‘COVID-19 Indo-U.S. Virtual Networks’ that would allow Indian and U.S. scientists and engineers currently engaged in COVID-related research to carry out joint research activities through a virtual mechanism.

Read More

Apr 13, 2020

By : Team ABLE

DST researchers explore novel blood plasma therapy for COVID-19

The treatment aims at using the immune power gained by a recovered person to treat a sick person

Read More

Apr 13, 2020

By : Team ABLE

DBT/Anti-COVID consortium make efforts to produce therapeutic antibodies against COVID-19

Isolating genes encoding antibodies for neutralising the SARS-CoV-2, COVID-19 is underway

Read More

Apr 13, 2020

By : Team ABLE

DST funded startup develops kits for testing asymptomatic COVID-19 infections & gears up for vaccine production

Developing vaccines has the longest timeline and so it is essential to fast track that activity NOW,” says Professor Ashutosh Sharma, Secretary, DST

Read More

Apr 13, 2020

By : Team ABLE

 

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Indian Startup Delegations to the USA & UK

Applications Open

Focus Areas

Highlights